Atlas Trials

Ivermectin Nasal Spray for COVID19 Patients

Clinical trial NCT04510233 · UNKNOWN

Trial details

NCT number
NCT04510233
Sponsor
Tanta University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Covid19
Start date
2020-09-01
Primary completion
2020-10-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.